JPRN-UMIN000018235已完成未知
Study of outcome measures in muscular dystrophy clinical trials - MDCTN-OM
Muscular Dystrophy Clinical Trial Network0 个研究点目标入组 50 人开始时间: 2015年7月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 6years-old 至 12years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •a) Patients with obvious heart failure and respiratory failure in the judgement of principal investigator or sub-investigator. b) Patients with persistent artificial ventilation (excepting the use of Noninvasive Positive Pressure Ventilation (NPPV) at night). c) Patients with behavioral problems interfered with motor function test such as intellectual disability, autism, attention-deficit hyperactivity disorder in the judgement of principal investigator or sub-investigator. d) Patients who were considered inappropriate for this study by principal investigator or sub-investigator for other reason. e) Patients who are part of other clinical trials now.
研究者
相似试验
招募中
不适用
Outcome measures in Duchenne Muscular Dystrophy: A Natural History Study1002839610028302Duchenne Muscular DystrophyNL-OMON50307eids Universitair Medisch Centrum20
已完成
不适用
evaluation of CNS in muscular dystrophyJPRN-UMIN000014250Center for Integrated Human Brain Science, Brain Research Institute, University of Niigata30
终止
不适用
Assessing Clinical Endpoints and Biomarkers in Myotonic Dystrophy Type-1 and Type 2 (ASCEND-DM)Myotonic Dystrophy Type-1Myotonic Dystrophy Type-2NCT03867435National Institute of Neurological Disorders and Stroke (NINDS)4
尚未招募
不适用
Observational Prolonged Trial in Myotonic Dystrophy type 1 to Improve Qol Standards, a Taget Identification Collaboration.Myotonic Dystrofy type 1 and Dystrofia Myotonica (DM1)10029317NL-OMON38289niversitair Medisch Centrum Sint Radboud72
招募中
不适用
Biomarker Development for Muscular DystrophiesBecker Muscular DystrophyMyotonic DystrophyFacioscapulohumeral Muscular DystrophyDuchenne Muscular DystrophyNCT05019625Massachusetts General Hospital465